Skip to main content

Market Overview

Mead Johnson Details New Production Expansion In China


Mead Johnson Nutrition CO (NYSE: MJN) announced on Monday that it plans on launching its new Enfinitas premium-priced product line in China.

Mead Johnson stated that it will begin rolling out its new product line "over the coming weeks." The company added that its product is customized for the China market and contains Lactoferrin and Milk Fat Globule Membrane.

Mead Johnson added that it will provide additional information during its 2016 first quarter earnings conference call.

Related Link: Credit Suisse Sees Two Ways To Win In Mead Johnson Takeover

"As noted previously, Mead Johnson continually strives to further broaden our science-based product portfolio," commented Kasper Jakobsen, President and CEO. "We are pleased to be introducing Enfinitas and its meaningful benefits to consumers in China in support of our mission to help nourish the world's children for the best start in life. Over time, we expect this product to strengthen our competitiveness in the fastest-growing segment of our category in China."

Shares of Mead Johnson showed no trades early Monday morning and have lost more than 18 percent over the past year.


Related Articles (MJN)

View Comments and Join the Discussion!

Posted-In: Baby Formula Enfinitas Kasper Jakobsen mead johnsonNews Emerging Markets Markets Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at